![Seeking Alpha](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/665/normal/Screen_Shot_2016-01-26_at_13.35.16.png?1453815336)
Prothena: I'm Not A Buyer At A $3 Billion Valuation
Seeking Alpha,
Follow Summary Prothena has several interesting drug candidates for Alzheimer’s, Parkinson’s and two rare diseases.
Follow Summary Prothena has several interesting drug candidates for Alzheimer’s, Parkinson’s and two rare diseases.
Krafft GA, Jerecic J, Siemers E, Cline EN. Front Neurosci. 2022;16:848215. Epub 2022 Apr 26 PubMed.
Acumen Pharmaceuticals Reports Financial Results for First Quarter 2022 and Business Highlights Topline results expected in the…
Acumen Pharmaceuticals Reports Financial Results for First Quarter 2022 and Business Highlights GlobeNewswire 2022-05-16…